Centrica plc has announced that two of its directors, Christopher O'Shea and Russell O'Brien, have acquired shares in the company through the reinvestment of dividends under the company's Share Incentive Plan. O'Shea, an Executive Director, acquired 147 ordinary shares at a price of £1.4964 per share, totaling £219.97. O'Brien, also an Executive Director, acquired 8 ordinary shares at the same price, totaling £11.97. The transactions took place on 16 November 2023 on the London Stock Exchange. Centrica plc is listed on the London Stock Exchange and its registered office is in Windsor, Berkshire.